This study is a traditional Chinese medicine cohort for interstitial lung disease（ILD） in China, including at least 5000 patients with ILD and followed up for at least 5 years. The aim is to focus on the demographic characteristics, clinical features, disease occurrence and development characteristics, TCM syndrome evolution patterns, and clinical efficacy of TCM treatment for ILD in the real world.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Patients who meet the diagnosis of ILD;
2. Age≥18 years old;
3. Ability to provide independent informed consent.
Exclusion Criteria:
Patients with acute ILD caused by known reasons, but the lesions disappear within 2 weeks after treatment. Example: Interstitial pneumonia caused by infections such as mycoplasma/virus, and those who recover after treatment are excluded.
Primary outcome measure(s)
All-cause mortality — up to week 13, 26, 39, 52, 65, 78 ,91 and 104 weeks. The all-cause mortality will be recorded.
Lung transplantation — Up to week 13, 26, 39, 52, 65, 78 ,91 and 104 weeks. The lung transplantation will be calculated in each cohort at the end of the trial.
Trial sites (1)
Facility
City
Region
Status
The First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou
Henan
Recruiting
More Henan University of Traditional Chinese Medicine trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.